Methods |
random number tables, sealed opaque envelopes |
Participants |
86 pregnant women, =/> 18 years, ≤ 49 days pregnant, single pregnancy, at the University hospital Pittsburgh, USA
exclusion criteria: contraindication to mifepristone/misoprostol administration, haemoglobin < 10 gm/dL, cardiovascular disease, coagulopathies, IUCD in situ, breastfeeding |
Interventions |
mifepristone 600mg (all)
group 1: misoprostol 400mcg after 6‐8 hours/oral
group 2: misoprostol 400mcg after 48 hours/oral |
Outcomes |
complete abortion, onset and duration of bleeding, side effects |
Notes |
no blinding
no major complications were reported |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Allocation concealment (selection bias) |
Low risk |
A ‐ Adequate |